Revenue Growth (YoY)
Higher than 50% of Healthcare sector peers
Updated 166h ago
Sector Performance
50th percentileTMO
6.2%
Sector Median
6.2%
Sector Avg
3.8%
Deep Analysis
Thermo Fisher Scientific Inc. (TMO) has a Revenue Growth (YoY) of 6.2% as of June 2026.
This places TMO in the 50th percentile of the Healthcare sector, which has a median Revenue Growth (YoY) of 6.2% and a sector average of 3.8%. TMO's Revenue Growth (YoY) is 0.0% above the sector median. In context: Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
Frequently Asked Questions
What does the Revenue Growth (YoY) tell investors about TMO?
Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
How is the Revenue Growth (YoY) calculated?
Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.
How does TMO's Revenue Growth (YoY) compare to its sector?
TMO's Revenue Growth (YoY) of 6.2% compares to a Healthcare sector median of 6.2%, placing it in the 50th percentile.
Who are TMO's closest peers by Revenue Growth (YoY)?
The closest Healthcare peers by Revenue Growth (YoY) include: AMGN (5.8%), CPRX (5.6%), HIMS (3.8%), BAX (2.9%), BMY (2.6%).
The Formula
(Revenue_t - Revenue_t-4) / Revenue_t-4
Why It Matters
Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
Master TMO's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full TMO research report →TMO
6.2%
Sector Median
6.2%
Sector Avg
3.8%
How TMO's Revenue Growth (YoY) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.